Novartis Announces Acquisition of MorphoSys for $2.9 Billion
In a strategic move aimed at bolstering its cancer treatment portfolio, Novartis AG has declared its intention to acquire MorphoSys…
novartis
U.S. Sues Novartis Over Medicare Fraud
On Tuesday, the U.S. government filed a civil fraud lawsuit accusing a unit of Novartis AG of orchestrating claims based…
India Responds to IP Issues Raised Over Novartis Case
On his visit to the World Intellectual Property Organization in Geneva, India’s Trade Minister Anand Sharma gave some straightforward answers…
European Approval Granted for Novartis’s Meningitis B Vaccine
Approval has been granted to Novartis for the very first vaccine that would fight meningitis B, according to Reuters. Now,…